tiprankstipranks
Trending News
More News >
HemoGenyx Pharmaceuticals Plc (GB:HEMO)
LSE:HEMO
UK Market

HemoGenyx Pharmaceuticals Plc (HEMO) Income Statement

Compare
34 Followers

HemoGenyx Pharmaceuticals Plc Income Statement

Last quarter (Q2 2025), HemoGenyx Pharmaceuticals Plc's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q2, HemoGenyx Pharmaceuticals Plc's net income was £-5.00M. See HemoGenyx Pharmaceuticals Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ -639.28K£ -645.68K£ -2.60M£ -283.65K£ -350.72K
Operating Expenses
£ 5.09M£ 4.91M£ 2.93M£ 2.70M£ 1.87M
Depreciation and Amortization
£ 639.28K£ 645.68K£ 564.07K£ 126.34K£ 106.75K
EBITDA
£ -4.71M£ -5.73M£ -3.42M£ -2.39M£ -1.96M
Operating Income
£ -5.73M£ -5.56M£ 4.00M£ -2.70M£ -2.15M
Other Income/Expenses
£ 101.22K£ -1.14M£ 1.54M£ -2.41M£ 55.36K
Pretax Income
£ -5.63M£ -6.70M£ -3.99M£ -5.11M£ -2.10M
Net Income
£ -5.62M£ -6.69M£ -3.98M£ -5.10M£ -2.08M
Per Share Metrics
Basic EPS
£ -1.70£ -2.37£ -1.62£ -2.64£ -2.01
Diluted EPS
£ -1.70£ -2.37£ -1.62£ -2.64£ -2.01
Weighted Average Shares Outstanding
3.30M 2.82M 2.45M 1.93M 1.04M
Weighted Average Shares Outstanding (Diluted)
3.30M 2.82M 2.45M 1.93M 1.04M
Currency in GBP

HemoGenyx Pharmaceuticals Plc Earnings and Revenue History